Morgan Stanley
HHS icon

Morgan Stanley’s Harte-Hanks HHS Stock Holding History

Morgan Stanley’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Hold
7
– – ﹤0.01% 8186
2025
Q4 		$21 Hold
7
– – ﹤0.01% 8075
2025
Q3 		$26 Hold
7
– – ﹤0.01% 8011
2025
Q2 		$28 Sell
7
-50
-88% -$224 ﹤0.01% 7935
2025
Q1 		$274 Hold
57
– – ﹤0.01% 7436
2024
Q4 		$294 Hold
57
– – ﹤0.01% 7383
2024
Q3 		$424 Sell
57
-88
-61% -$690 ﹤0.01% 7318
2024
Q2 		$1.18K Buy
145
+88
+154% +$642 ﹤0.01% 7137
2024
Q1 		$426 Sell
57
-57
-50% -$434 ﹤0.01% 7254
2023
Q4 		$776 Buy
114
+57
+100% +$380 ﹤0.01% 7238
2023
Q3 		$372 Hold
57
– – ﹤0.01% 7337
2023
Q2 		$312 Hold
57
– – ﹤0.01% 7418
2023
Q1 		$537 Sell
57
-1
-2% -$11 ﹤0.01% 7422
2022
Q4 		$679 Sell
58
-795
-93% -$8.8K ﹤0.01% 7526
2022
Q3 		$9K Buy
853
+796
+1,396% +$10.6K ﹤0.01% 7105
2022
Q2 		$1K Sell
57
-559
-91% -$4.89K ﹤0.01% 7681
2022
Q1 		$4K Hold
616
– – ﹤0.01% 7631
2021
Q4 		$4K Buy
+616
New +$4.89K ﹤0.01% 7684
2020
Q3 		– Sell
-1,133
Closed -$4K – 6774
2020
Q2 		$4K Buy
1,133
+499
+79% +$1.18K ﹤0.01% 6341
2020
Q1 		$1K Sell
634
-1
-0.2% -$3 ﹤0.01% 6460
2019
Q4 		$2K Buy
635
+5
+0.8% +$15 ﹤0.01% 6500
2019
Q3 		$2K Buy
630
+46
+8% +$145 ﹤0.01% 6479
2019
Q2 		$1K Sell
584
-46
-7% -$146 ﹤0.01% 6539
2019
Q1 		$2K Buy
630
+569
+933% +$1.98K ﹤0.01% 6454
2018
Q4 		$0 Hold
61
– – ﹤0.01% 6643
2018
Q3 		$0 Sell
61
-3,449
-98% -$30.3K ﹤0.01% 6744
2018
Q2 		$39K Sell
3,510
-13,596
-79% -$139K ﹤0.01% 5975
2018
Q1 		$157K Sell
17,106
-807
-5% -$7.38K ﹤0.01% 5565
2017
Q4 		$170K Sell
17,913
-437
-2% -$4.41K ﹤0.01% 5469
2017
Q3 		$197K Sell
18,350
-10,203
-36% -$93.9K ﹤0.01% 5359
2017
Q2 		$294K Sell
28,553
-3,970
-12% -$50.1K ﹤0.01% 5121
2017
Q1 		$455K Sell
32,523
-3,089
-9% -$47K ﹤0.01% 4894
2016
Q4 		$538K Sell
35,612
-3,106
-8% -$47.1K ﹤0.01% 4891
2016
Q3 		$627K Sell
38,718
-15,957
-29% -$263K ﹤0.01% 4388
2016
Q2 		$869K Sell
54,675
-13,321
-20% -$235K ﹤0.01% 4078
2016
Q1 		$1.72M Sell
67,996
-11,092
-14% -$341K ﹤0.01% 3472
2015
Q4 		$2.56M Buy
79,088
+5,293
+7% +$198K ﹤0.01% 3279
2015
Q3 		$2.6M Buy
73,795
+28,009
+61% +$1.26M ﹤0.01% 3256
2015
Q2 		$2.73M Buy
45,786
+25,015
+120% +$1.68M ﹤0.01% 3334
2015
Q1 		$1.62M Buy
20,771
+983
+5% +$76K ﹤0.01% 3774
2014
Q4 		$1.53M Buy
19,788
+16,187
+450% +$1.06M ﹤0.01% 3780
2014
Q3 		$229K Buy
3,601
+2,413
+203% +$164K ﹤0.01% 5067
2014
Q2 		$85K Sell
1,188
-7,141
-86% -$551K ﹤0.01% 5563
2014
Q1 		$736K Sell
8,329
-8,436
-50% -$657K ﹤0.01% 4256
2013
Q4 		$1.31M Sell
16,765
-30,212
-64% -$2.46M ﹤0.01% 3713
2013
Q3 		$4.15M Buy
46,977
+5,495
+13% +$503K ﹤0.01% 2608
2013
Q2 		$3.57M Buy
+41,482
New +$3.43M ﹤0.01% 2643

Other funds holding HHS

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Morgan Stanley's HHS Position: Q1 2026 in Review

Morgan Stanley held its Harte-Hanks (HHS) position steady in Q1 2026 at 7 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #8186.

Morgan Stanley first reported a position in HHS in Q2 2013 and has held it in 47 quarters since. The position peaked at $4.15M in Q3 2013. 22 funds tracked by Wall St. Rank hold HHS as of Q1 2026.

  • Morgan Stanley held 7 shares of Harte-Hanks worth $16 as of Q1 2026.
  • Morgan Stanley left its Harte-Hanks share count unchanged in Q1 2026.
  • Harte-Hanks made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8186 holding.
  • Morgan Stanley first reported a position in Harte-Hanks in Q2 2013 and has held it in 47 quarters since.
  • Morgan Stanley's Harte-Hanks position peaked at $4.15M in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.